Triac Trial II in MCT8 Deficiency Patients

NCT02396459 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Allan-Herndon-Dudley Syndrome

Interventions

DRUG: Tiratricol

Sponsor

Rare Thyroid Therapeutics International AB

Collaborators

[object Object]